Everlab Raises US$10 Million to Scale AI-Driven Preventive Health Platform Globally

Everlab, the AI-powered health platform reimagining preventive care, announced a US$10 million (AU$15 million) seed round led by global growth equity fir...

July 22, 2025 | Tuesday | News
Moderna Halts Plan for Japan mRNA API Facility Amid Market Shifts, Completes Enzymatics R&D Site at Shonan iPark

Moderna provided an update on its two planned research and manufacturing facilities at Shonan Health Innovation Park (iPark) in Fujisawa, Kanagawa Prefectu...

July 22, 2025 | Tuesday | News
Gelteq Partners with IDT Australia to Establish Dedicated Manufacturing Facility for Global Gel-Based Therapeutics

Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based company focused on developing and commercializing white ...

July 21, 2025 | Monday | News
Imugene Reports 75% Overall Response Rate in U.S.–Australia Phase 1b Trial of Off-the-Shelf CAR T Therapy for Relapsed DLBCL

Since the February update, an additional 5 patients have been dosed, resulting in 2 Complete Responses (CR) and 3 Partial Responses (PR) 75% Overall R...

July 15, 2025 | Tuesday | News
iFIT and Samsung Health Partner to Redefine Connected Fitness and Personalised Healthcare Globally

iFIT, a global leader in connected fitness and interactive content,  announced a groundbreaking partnership with Samsung Health, one of the world&rs...

July 14, 2025 | Monday | News
Japan’s Chugai and Singapore’s Gero Join Forces to Advance Antibody Therapies Targeting Aging via AI and Human Data

Collaboration to create novel antibody drug candidates using Chugai's proprietary antibody engineering technologies for drug targets identified through...

July 08, 2025 | Tuesday | News
Nxera Pharma to Receive US$4.8 Million in Milestone Payments as Centessa Advances Orexin Agonist into Clinical Development

Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that it will receive US$4.8 million in milestone paym...

July 07, 2025 | Monday | News
Valneva Partners with CSL Seqirus to Distribute Chikungunya, Japanese Encephalitis, and Cholera Vaccines in Germany

Valneva SE, , a specialty vaccine company, announced an exclusive agreement with CSL Seqirus, one of the world’s largest influenza vaccine companie...

June 30, 2025 | Monday | News
Singapore’s Gero Launches ProtoBind-Diff, a Sequence-Only AI Model Generating Drug-Like Molecules Without 3D Structures

ProtoBind-Diff generates drug-like molecules for specific protein targets using only their amino acid sequences—no 3D structures required. The m...

June 30, 2025 | Monday | News
Cytiva’s “In-Region, For-Region” Strategy Powers $1.6 Billion Global Biomanufacturing Expansion

Since 2019, Cytiva has committed over $1.6 billion to expand its global manufacturing capacity. In this exclusive conversation with BioPharma BoardRoom, Pi...

July 01, 2025 | Tuesday | Interview
Liquid Instruments Partners with Scanfil to Onshore Moku Platform Production in Australia

Scanfil and Liquid Instruments have signed a manufacturing outsourcing agreement for Scanfil’s Melbourne plant in Australia. This agreement support...

June 26, 2025 | Thursday | News
Noxopharm Advances HERACLES Trial with Rapid Recruitment for First-in-Human SOF-SKN™ Study in Autoimmune Diseases

Clinical-stage biotech company Noxopharm Limited (ASX:NOX) is pleased to announce that recruitment activities are progressing rapidly and on sche...

June 25, 2025 | Wednesday | News
Nutriband and Kindeva Complete Commercial Manufacturing Scale-Up for AVERSA™ Fentanyl, Advancing World’s First Abuse-Deterrent Opioid Patch

Nutriband Inc.  a company engaged in the development of prescription transdermal pharmaceutical products, announced that it has completed commercial...

June 24, 2025 | Tuesday | News
Incannex and Mind Medicine Australia Launch Joint Venture to Open Psychedelic Therapies Clinic in Melbourne

Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing combi...

June 18, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close